(function(){var loadHandler=window['sl_{21FEF8D7-4385-4DEB-B34B-7A4BB675EF9A}'];loadHandler&&loadHandler(1, '<div id="spr0_158711dc"><div id="spr1_158711dc" class="kern slide"><img id="img8_158711dc" src="data/img8.png" width="720px" height="540px" alt="" style="left:0px;top:0px;"/></div><div id="spr2_158711dc" class="kern slide"><img id="img0_158711dc" src="data/img9.png" width="721.48" height="35.809" alt="" style="left:-0.439px;top:504.191px;"/><img id="img1_158711dc" src="data/img1.png" width="721.48" height="100.8" alt="" style="left:-0.439px;"/><div id="spr3_158711dc" style="left:657.715px;top:502.143px;"><img id="img2_158711dc" src="data/img3.png" width="56" height="36" alt="CHRC logo_with text.psd" style="left:-0.105px;top:-0.177px;"/></div><div id="spr4_158711dc" style="left:27.74px;top:3.812px;"><div style="width:0px;"><span id="txt0_158711dc" data-width="630.000000" style="left:18.255px;top:5.272px;">Evolocumab Cardiovascular Outcomes Trial:</span></div><div style="width:0px;"><span id="txt1_158711dc" data-width="242.736328" style="left:210.885px;top:48.472px;">Study Population</span></div></div><div id="spr5_158711dc" style="left:4.43px;top:500.747px;"><div style="width:0px;"><span id="txt2_158711dc" class="nokern" data-width="183.005859" style="left:7.2px;top:14.896px;">Sabatine MS, et al . N Engl J Med 2017; 376:1713-1722</span></div></div><div id="spr6_158711dc" style="left:27px;top:160px;"><div style="width:0px;"><span id="txt3_158711dc" data-width="71.367188" style="left:83.871px;top:18.157px;">Screening</span></div><div style="width:0px;"><span id="txt4_158711dc" style="left:119.621px;top:39.572px;"> </span></div><div style="width:0px;"><span id="txt5_158711dc" class="nokern relpos" style="left:10.061px;top:56.843px;"></span><span id="txt6_158711dc" class="relpos" style="left:26.156px;top:56.372px;">A</span><span id="txt7_158711dc" class="relpos" data-width="79.146484" style="left:26.151px;top:56.372px;">ge 40-85 years</span></div><div style="width:0px;"><span id="txt8_158711dc" class="nokern relpos" style="left:10.061px;top:73.643px;"></span><span id="txt9_158711dc" class="relpos" style="left:26.156px;top:73.172px;">M</span><span id="txt10_158711dc" class="relpos" data-width="87.390625" style="left:26.151px;top:73.172px;">I, Stroke or PAD</span></div><div style="width:0px;"><span id="txt11_158711dc" class="nokern relpos" style="left:10.061px;top:90.443px;"></span><span id="txt12_158711dc" class="relpos" style="left:26.156px;top:89.972px;">A</span><span id="txt13_158711dc" class="relpos" data-width="174.801758" style="left:26.151px;top:89.972px;">dditional risk factors (one major</span></div><div style="width:0px;"><span id="txt14_158711dc" data-width="73.342773" style="left:32.561px;top:106.772px;">or two minor)</span></div><div style="width:0px;"><span id="txt15_158711dc" class="nokern relpos" style="left:10.061px;top:124.043px;"></span><span id="txt16_158711dc" class="relpos" style="left:26.156px;top:123.572px;">O</span><span id="txt17_158711dc" class="relpos" data-width="174.159180" style="left:26.151px;top:123.572px;">ptimal background lipid therapy</span></div><div style="width:0px;"><span id="txt18_158711dc" data-width="193.327148" style="left:32.561px;top:140.372px;">(including effective dose of statin ±</span></div><div style="width:0px;"><span id="txt19_158711dc" data-width="56.143555" style="left:32.561px;top:157.172px;">ezetimibe)</span></div><div style="width:0px;"><span id="txt20_158711dc" class="nokern relpos" style="left:10.061px;top:174.443px;"></span><span id="txt21_158711dc" class="relpos" style="left:26.156px;top:173.972px;">L</span><span id="txt22_158711dc" class="relpos" data-width="185.623047" style="left:26.151px;top:173.972px;">DL-C ≥ 1.81 mmol/L or non HDL-C</span></div><div style="width:0px;"><span id="txt23_158711dc" data-width="77.239258" style="left:32.561px;top:190.772px;">≥ 2.59 mmol/L</span></div></div><div id="spr7_158711dc" style="left:27px;top:160px;"><img id="img3_158711dc" src="data/img10.png" width="241" height="225" alt=""/></div><div id="spr8_158711dc" style="left:27px;top:160px;"><div style="width:0px;"><span id="txt24_158711dc" data-width="71.367188" style="left:81.75px;top:16.036px;">Screening</span></div><div style="width:0px;"><span id="txt25_158711dc" style="left:117.5px;top:37.45px;"> </span></div><div style="width:0px;"><span id="txt26_158711dc" class="nokern relpos" style="left:7.94px;top:54.722px;"></span><span id="txt27_158711dc" class="relpos" style="left:24.035px;top:54.25px;">A</span><span id="txt28_158711dc" class="relpos" data-width="79.146484" style="left:24.03px;top:54.25px;">ge 40-85 years</span></div><div style="width:0px;"><span id="txt29_158711dc" class="nokern relpos" style="left:7.94px;top:71.522px;"></span><span id="txt30_158711dc" class="relpos" style="left:24.035px;top:71.05px;">M</span><span id="txt31_158711dc" class="relpos" data-width="87.390625" style="left:24.03px;top:71.05px;">I, Stroke or PAD</span></div><div style="width:0px;"><span id="txt32_158711dc" class="nokern relpos" style="left:7.94px;top:88.322px;"></span><span id="txt33_158711dc" class="relpos" style="left:24.035px;top:87.85px;">A</span><span id="txt34_158711dc" class="relpos" data-width="174.801758" style="left:24.03px;top:87.85px;">dditional risk factors (one major</span></div><div style="width:0px;"><span id="txt35_158711dc" data-width="73.342773" style="left:30.44px;top:104.65px;">or two minor)</span></div><div style="width:0px;"><span id="txt36_158711dc" class="nokern relpos" style="left:7.94px;top:121.922px;"></span><span id="txt37_158711dc" class="relpos" style="left:24.035px;top:121.45px;">O</span><span id="txt38_158711dc" class="relpos" data-width="174.159180" style="left:24.03px;top:121.45px;">ptimal background lipid therapy</span></div><div style="width:0px;"><span id="txt39_158711dc" data-width="193.327148" style="left:30.44px;top:138.25px;">(including effective dose of statin ±</span></div><div style="width:0px;"><span id="txt40_158711dc" data-width="56.143555" style="left:30.44px;top:155.05px;">ezetimibe)</span></div><div style="width:0px;"><span id="txt41_158711dc" class="nokern relpos" style="left:7.94px;top:172.322px;"></span><span id="txt42_158711dc" class="relpos" style="left:24.035px;top:171.85px;">L</span><span id="txt43_158711dc" class="relpos" data-width="185.623047" style="left:24.03px;top:171.85px;">DL-C ≥ 1.81 mmol/L or non HDL-C</span></div><div style="width:0px;"><span id="txt44_158711dc" data-width="77.239258" style="left:30.44px;top:188.65px;">≥ 2.59 mmol/L</span></div></div><div id="svg7_158711dc" style="left:259.071px;top:266.651px;"><svg width="32" height="7" viewBox="-2.25 -0 32 7"><g fill="none"><g transform="translate(0,3.348816)"><g fill="#404040" stroke="none" transform="translate(-0.000003,-3.348825)"><path stroke="#404040" stroke-width="2.25" stroke-linecap="butt" transform="translate(0.000003,3.348825)" d="M0,0 L22.772,0"/><path transform="matrix(1,-0.000003,0.000003,1,0.000003,3.348903)" d="M28.8,0 L22.102,3.349 V-3.349 Z"/></g></g></g></svg></div><div id="spr9_158711dc" style="left:289px;top:160px;"><div style="width:0px;"><span id="txt45_158711dc" data-width="102.060547" style="left:13.27px;top:158.809px;">Randomization 1:1</span></div></div><div id="spr10_158711dc" style="left:289px;top:160px;"><img id="img4_158711dc" src="data/img11.png" width="45" height="225" alt=""/></div><div id="spr11_158711dc" style="left:289px;top:160px;"><div style="width:0px;"><span id="txt46_158711dc" data-width="102.060547" style="left:11.148px;top:160.93px;">Randomization 1:1</span></div></div><div id="svg58_158711dc" style="left:323.424px;top:267.75px;"><svg width="27" height="5" viewBox="-2.25 -1.125 27 5"><g fill="#404040" stroke="none"><path stroke="#404040" stroke-width="2.25" stroke-linecap="butt" transform="translate(-325.674438,-268.874908)" d="M325.674,270 H347.274"/></g></svg></div><div id="svg61_158711dc" style="left:346.149px;top:215.461px;"><svg width="113" height="5" viewBox="-2.25 -1.125 113 5"><g fill="#404040" stroke="none"><path stroke="#404040" stroke-width="2.25" stroke-linecap="butt" transform="translate(-293.274414,-269.46106)" d="M293.274,270.586 H401.274"/></g></svg></div><div id="svg21_158711dc" style="left:344.051px;top:320.858px;"><svg width="32" height="7" viewBox="-2.25 -0 32 7"><g fill="none"><g transform="translate(0,3.348816)"><g fill="#404040" stroke="none" transform="translate(-0.000003,-3.348825)"><path stroke="#404040" stroke-width="2.25" stroke-linecap="butt" transform="translate(0.000003,3.348825)" d="M0,0 L22.772,0"/><path transform="matrix(1,-0.000003,0.000003,1,0.000003,3.348903)" d="M28.8,0 L22.102,3.349 V-3.349 Z"/></g></g></g></svg></div><div id="svg29_158711dc" style="left:345.024px;top:213.979px;"><svg width="32" height="7" viewBox="-2.25 -0 32 7"><g fill="none"><g transform="translate(0,3.348831)"><g fill="#404040" stroke="none" transform="translate(-0.000003,-3.348825)"><path stroke="#404040" stroke-width="2.25" stroke-linecap="butt" transform="translate(0.000003,3.348825)" d="M0,0 L22.772,0"/><path transform="matrix(1,-0.000003,0.000003,1,0.000003,3.348903)" d="M28.8,0 L22.102,3.349 V-3.349 Z"/></g></g></g></svg></div><div id="spr12_158711dc" style="left:376px;top:160px;"><div style="width:0px;"><span id="txt47_158711dc" data-width="87.397461" style="left:76px;top:21.99px;">Evolocumab SC</span></div><div style="width:0px;"><span id="txt48_158711dc" data-width="148.032227" style="left:45.5px;top:38.79px;">140 mg Q2W or 420 mg QM</span></div><div style="width:0px;"><span id="txt49_158711dc" data-width="130.785156" style="left:54.125px;top:55.59px;">(per subject preference)</span></div><div style="width:0px;"><span id="txt50_158711dc" data-width="55.220703" style="left:92px;top:72.39px;">n ~ 13,750</span></div></div><div id="spr13_158711dc" style="left:376px;top:160px;"><img id="img5_158711dc" src="data/img12.png" width="241" height="109" alt=""/></div><div id="spr14_158711dc" style="left:376px;top:160px;"><div style="width:0px;"><span id="txt51_158711dc" data-width="87.397461" style="left:73.878px;top:19.869px;">Evolocumab SC</span></div><div style="width:0px;"><span id="txt52_158711dc" data-width="148.032227" style="left:43.378px;top:36.669px;">140 mg Q2W or 420 mg QM</span></div><div style="width:0px;"><span id="txt53_158711dc" data-width="130.785156" style="left:52.003px;top:53.469px;">(per subject preference)</span></div><div style="width:0px;"><span id="txt54_158711dc" data-width="55.220703" style="left:89.878px;top:70.269px;">n ~ 13,750</span></div></div><div id="spr15_158711dc" style="left:375px;top:281px;"><div style="width:0px;"><span id="txt55_158711dc" data-width="63.164063" style="left:88.424px;top:21.176px;">Placebo SC</span></div><div style="width:0px;"><span id="txt56_158711dc" data-width="62.514648" style="left:88.674px;top:37.976px;">Q2W or QM</span></div><div style="width:0px;"><span id="txt57_158711dc" data-width="130.785156" style="left:54.424px;top:54.776px;">(per subject preference)</span></div><div style="width:0px;"><span id="txt58_158711dc" data-width="55.220703" style="left:92.299px;top:71.576px;">n ~ 13,750</span></div></div><div id="spr16_158711dc" style="left:375px;top:281px;"><img id="img6_158711dc" src="data/img13.png" width="243" height="109" alt=""/></div><div id="spr17_158711dc" style="left:375px;top:281px;"><div style="width:0px;"><span id="txt59_158711dc" data-width="63.164063" style="left:86.303px;top:19.054px;">Placebo SC</span></div><div style="width:0px;"><span id="txt60_158711dc" data-width="62.514648" style="left:86.553px;top:35.854px;">Q2W or QM</span></div><div style="width:0px;"><span id="txt61_158711dc" data-width="130.785156" style="left:52.303px;top:52.654px;">(per subject preference)</span></div><div style="width:0px;"><span id="txt62_158711dc" data-width="55.220703" style="left:90.178px;top:69.454px;">n ~ 13,750</span></div></div><div id="svg64_158711dc" style="left:607.269px;top:212.522px;"><svg width="27" height="5" viewBox="-2.25 -1.125 27 5"><g fill="#404040" stroke="none"><path stroke="#404040" stroke-width="2.25" stroke-linecap="butt" transform="translate(-609.519287,-213.647049)" d="M609.519,214.772 H631.119"/></g></svg></div><div id="svg67_158711dc" style="left:607.269px;top:319.892px;"><svg width="27" height="5" viewBox="-2.25 -1.125 27 5"><g fill="#404040" stroke="none"><path stroke="#404040" stroke-width="2.25" stroke-linecap="butt" transform="translate(-609.519287,-321.016876)" d="M609.519,322.142 H631.119"/></g></svg></div><div id="svg70_158711dc" style="left:629.436px;top:213.089px;"><svg width="113" height="5" viewBox="-2.25 -1.125 113 5"><g fill="#404040" stroke="none"><path stroke="#404040" stroke-width="2.25" stroke-linecap="butt" transform="translate(-576.561157,-267.088928)" d="M576.561,268.214 H684.561"/></g></svg></div><div id="svg46_158711dc" style="left:629.316px;top:264.865px;"><svg width="17" height="7" viewBox="-2.25 -0 17 7"><g fill="none"><g transform="translate(0,3.348816)"><g fill="#404040" stroke="none" transform="translate(-0.000006,-3.348807)"><path stroke="#404040" stroke-width="2.25" stroke-linecap="butt" transform="translate(0.000006,3.348807)" d="M0,0 L8.372,0"/><path transform="matrix(1,-0.000006,0.000006,1,0.000006,3.348886)" d="M14.4,0 L7.702,3.349 V-3.349 Z"/></g></g></g></svg></div><div id="spr18_158711dc" style="left:645px;top:161px;"><div style="width:0px;"><span id="txt63_158711dc" data-width="105.875000" style="left:13.199px;top:160.335px;">End of Study (EOS)</span></div></div><div id="spr19_158711dc" style="left:645px;top:161px;"><img id="img7_158711dc" src="data/img14.png" width="45" height="223" alt=""/></div><div id="spr20_158711dc" style="left:645px;top:161px;"><div style="width:0px;"><span id="txt64_158711dc" data-width="105.875000" style="left:11.077px;top:162.456px;">End of Study (EOS)</span></div></div><div id="svg73_158711dc" style="left:26.406px;top:400.22px;"><svg width="349" height="3" viewBox="-1.5 -0.75 349 3"><g fill="#404040" stroke="none"><path stroke="#404040" stroke-width="1.5" stroke-linecap="butt" stroke-dasharray="6,4.5" transform="translate(-27.905914,-400.970306)" d="M27.906,401.72 H373.506"/></g></svg></div><div id="svg76_158711dc" style="left:374.882px;top:400.22px;"><svg width="184" height="3" viewBox="-1.5 -0.75 184 3"><g fill="#404040" stroke="none"><path stroke="#404040" stroke-width="1.5" stroke-linecap="butt" transform="translate(-376.381592,-400.970306)" d="M376.382,401.72 H556.382"/></g></svg></div><div id="svg79_158711dc" style="left:557.477px;top:400.22px;"><svg width="126" height="3" viewBox="-1.5 -0.75 126 3"><g fill="#404040" stroke="none"><path stroke="#404040" stroke-width="1.5" stroke-linecap="butt" stroke-dasharray="6,4.5" transform="translate(-558.976746,-400.970306)" d="M558.977,401.72 H681.377"/></g></svg></div><div id="spr21_158711dc" style="left:20.26px;top:405.348px;"><div style="width:0px;"><span id="txt65_158711dc" data-width="160.810547" style="left:92.175px;top:4.157px;">Maximum approximately 15 weeks</span></div></div><div id="spr22_158711dc" style="left:355.926px;top:403.999px;"><div style="width:0px;"><span id="txt66_158711dc" data-width="12.574219" style="left:11.688px;top:4.263px;">D1</span></div></div><div id="spr23_158711dc" style="left:396.294px;top:403.999px;"><div style="width:0px;"><span id="txt67_158711dc" data-width="14.759766" style="left:10.625px;top:4.263px;">W4</span></div></div><div id="spr24_158711dc" style="left:453.407px;top:403.999px;"><div style="width:0px;"><span id="txt68_158711dc" data-width="20.232422" style="left:11.475px;top:4.263px;">W12</span></div></div><div id="spr25_158711dc" style="left:519.394px;top:403.999px;"><div style="width:0px;"><span id="txt69_158711dc" data-width="20.232422" style="left:11.475px;top:4.263px;">W24</span></div></div><div id="spr26_158711dc" style="left:577.846px;top:403.999px;"><div style="width:0px;"><span id="txt70_158711dc" data-width="27.890625" style="left:17.388px;top:4.263px;">Q24W</span></div></div><div id="spr27_158711dc" style="left:641.353px;top:403.999px;"><div style="width:0px;"><span id="txt71_158711dc" data-width="37.171875" style="left:12.7px;top:4.404px;">Number</span></div><div style="width:0px;"><span id="txt72_158711dc" class="relpos" data-width="36.650391" style="left:10.51px;top:18.804px;">of key 2</span><span id="txt73_158711dc" class="relpos" style="left:10.505px;top:18.934px;">○</span></div><div style="width:0px;"><span id="txt74_158711dc" data-width="47.015625" style="left:7.825px;top:33.204px;">endpoints</span></div></div><div id="spr28_158711dc" style="left:17.322px;top:424.916px;"><div style="width:0px;"><span id="txt75_158711dc" data-width="189.458008" style="left:7.2px;top:4.25px;">Background lipid-lowering therapy</span></div><div style="width:0px;"><span id="txt76_158711dc" class="nokern relpos" style="left:7.2px;top:27.493px;"></span><span id="txt77_158711dc" class="relpos" data-width="526.818359" style="left:23.295px;top:27.171px;">Patients must be on an optimized lipid-lowering regimen (moderate to high intensity statin +/- ezetimibe)</span></div><div style="width:0px;"><span id="txt78_158711dc" class="nokern relpos" style="left:7.2px;top:50.293px;"></span><span id="txt79_158711dc" class="relpos" data-width="532.300781" style="left:23.295px;top:49.971px;">In general, patients are not to change open-label background lipid-lowering therapies after randomization</span></div></div><div id="spr29_158711dc" style="left:32.486px;top:108.179px;"><div style="width:0px;"><span id="txt80_158711dc" class="relpos" data-width="82.910156" style="left:28.43px;top:4.744px;">FOURIER: </span><span id="txt81_158711dc" class="relpos" style="left:28.425px;top:4.529px;">F</span><span id="txt82_158711dc" class="relpos" data-width="157.705078" style="left:28.42px;top:4.744px;">urther cardiovascular </span><span id="txt83_158711dc" class="relpos" data-width="24.599609" style="left:28.415px;top:4.529px;">OU</span><span id="txt84_158711dc" class="relpos" data-width="57.431641" style="left:28.41px;top:4.744px;">tcomes </span><span id="txt85_158711dc" class="relpos" style="left:28.405px;top:4.529px;">R</span><span id="txt86_158711dc" class="relpos" data-width="154.960938" style="left:28.4px;top:4.744px;">esearch with PCSK9 </span><span id="txt87_158711dc" class="relpos" style="left:28.395px;top:4.529px;">I</span><span id="txt88_158711dc" class="relpos" data-width="78.417969" style="left:28.39px;top:4.744px;">nhibition in</span></div><div style="width:0px;"><span id="txt89_158711dc" class="relpos" data-width="98.457031" style="left:220.305px;top:28.744px;">subjects with </span><span id="txt90_158711dc" class="relpos" style="left:220.3px;top:28.529px;">E</span><span id="txt91_158711dc" class="relpos" data-width="57.451172" style="left:220.295px;top:28.744px;">levated </span><span id="txt92_158711dc" class="relpos" style="left:220.29px;top:28.529px;">R</span><span id="txt93_158711dc" class="relpos" data-width="20.048828" style="left:220.285px;top:28.744px;">isk</span></div></div></div></div>');})();